ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia.

Genes (Basel) · 2023 · PMC10379058 · PMID 37510370

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

a significant trendp = 0.001actually significant

Additionally, tumors bearing MGMT methylation had a significant trend toward lymph node metastasis ( p = 0.001), lymph invasion ( p = 0.005), venous invasion ( p = 0.004), perineural invasion ( p ≤ 0.001), distant metastasis ( p ≤ 0.001) and relapse ( p = 0.008).

also in 1,253 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.